Pulmonx (LUNG) Capital Expenditures (2019 - 2025)
Pulmonx (LUNG) reported Capital Expenditures of -$63000.0 for Q3 2025, down 105.4% year-over-year from $1.2 million in Q3 2024, and up 72.12% on a QoQ basis from -$226000.0 in Q2 2025.
Pulmonx (LUNG) has 7 years of Capital Expenditures data on file, last reported at -$63000.0 in Q3 2025.
- Quarterly Capital Expenditures fell 105.4% year-over-year to -$63000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$1.1 million (down 179.68% YoY) and the FY2024 annual result came in at $218000.0, up 100.0% from the prior year.
- Capital Expenditures climbed to -$63000.0 in Q3 2025 per LUNG's latest filing, from -$226000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.9 million in Q3 2021 and bottomed at -$1.1 million in Q4 2024.
- The 5-year median for Capital Expenditures is $279000.0 (2022), against an average of $233421.1.
- The widest annual swing landed in 2021, when Capital Expenditures surged 6000.0%; it then plunged 2250.0% in 2024.
- Tracing LUNG's Capital Expenditures over 5 years: stood at $1.1 million in 2021, then tumbled by 162.46% to -$717000.0 in 2022, then soared by 107.25% to $52000.0 in 2023, then sank by 2250.0% to -$1.1 million in 2024, then surged by 94.36% to -$63000.0 in 2025.
- Per Business Quant, the three latest LUNG Capital Expenditures figures stand at -$63000.0 (Q3 2025), -$226000.0 (Q2 2025), and $301000.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -63,000.00 |
| Sep 30, 2025 | -63,000.00 |
| Jun 30, 2025 | -226,000.00 |
| Jun 30, 2025 | -226,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Mar 31, 2025 | 301,000.00 |
| Dec 31, 2024 | -1.12 Mn |
| Dec 31, 2024 | -1.12 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | -282,000.00 |
| Jun 30, 2024 | -282,000.00 |
| Mar 31, 2024 | 451,000.00 |
| Mar 31, 2024 | 451,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Dec 31, 2023 | 52,000.00 |
| Sep 30, 2023 | -58,000.00 |
| Sep 30, 2023 | -58,000.00 |
| Jun 30, 2023 | -354,000.00 |
| Jun 30, 2023 | -354,000.00 |
| Mar 31, 2023 | 469,000.00 |
| Mar 31, 2023 | 469,000.00 |
| Dec 31, 2022 | -717,000.00 |
| Dec 31, 2022 | -717,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Sep 30, 2022 | 279,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 564,000.00 |
| Mar 31, 2022 | 564,000.00 |
| Dec 31, 2021 | 1.15 Mn |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.92 Mn |
| Sep 30, 2021 | 1.92 Mn |
| Jun 30, 2021 | 366,000.00 |
| Jun 30, 2021 | 366,000.00 |
| Mar 31, 2021 | 242,000.00 |
| Mar 31, 2021 | 242,000.00 |
| Dec 31, 2020 | -223,000.00 |
| Dec 31, 2020 | -223,000.00 |
| Sep 30, 2020 | 264,000.00 |
| Sep 30, 2020 | 264,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 18,000.00 |
| Mar 31, 2020 | 18,000.00 |
| Dec 31, 2019 | 221,000.00 |
| Dec 31, 2019 | 221,000.00 |